NEO

SEC source: 0001077183-24-000075 · wk-form4_1715737144.xml · nonDerivative · entry 1

Smith Christopher M · CIK 0001436707 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 650,282

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.

SEC source: 0001077183-24-000074 · wk-form4_1715737126.xml · derivative · entry 4

Olivo Alicia C · CIK 0001951869 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,006

Underlying: Common Stock · 6,502 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: On May 11, 2023, Ms. Olivo was granted 19,508 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F4 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-24-000074 · wk-form4_1715737126.xml · nonDerivative · entry 3

Olivo Alicia C · CIK 0001951869 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,916

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001077183-24-000074 · wk-form4_1715737126.xml · nonDerivative · entry 2

Olivo Alicia C · CIK 0001951869 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,414

F2 · shares: Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.

SEC source: 0001077183-24-000074 · wk-form4_1715737126.xml · nonDerivative · entry 1

Olivo Alicia C · CIK 0001951869 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,998

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.

SEC source: 0001077183-24-000073 · wk-form4_1715737110.xml · derivative · entry 4

Stone Warren · CIK 0001955295 · Chief Commerical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,226

Underlying: Common Stock · 9,612 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: On May 11, 2023, Mr. Stone was granted 28,838 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F4 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-24-000073 · wk-form4_1715737110.xml · nonDerivative · entry 3

Stone Warren · CIK 0001955295 · Chief Commerical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,658

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001077183-24-000073 · wk-form4_1715737110.xml · nonDerivative · entry 2

Stone Warren · CIK 0001955295 · Chief Commerical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,046

F2 · shares: Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.

SEC source: 0001077183-24-000073 · wk-form4_1715737110.xml · nonDerivative · entry 1

Stone Warren · CIK 0001955295 · Chief Commerical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,387

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.

SEC source: 0001077183-24-000072 · wk-form4_1715737091.xml · derivative · entry 4

Sherman Jeffrey Scott · CIK 0001463145 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,011

Underlying: Common Stock · 13,005 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: On May 11, 2023, Mr. Sherman was granted 39,016 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F4 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-24-000072 · wk-form4_1715737091.xml · nonDerivative · entry 3

Sherman Jeffrey Scott · CIK 0001463145 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 148,505

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001077183-24-000072 · wk-form4_1715737091.xml · nonDerivative · entry 2

Sherman Jeffrey Scott · CIK 0001463145 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,500

F2 · shares: Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.

SEC source: 0001077183-24-000072 · wk-form4_1715737091.xml · nonDerivative · entry 1

Sherman Jeffrey Scott · CIK 0001463145 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,667

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.

SEC source: 0001077183-24-000071 · wk-form4_1715737076.xml · derivative · entry 3

Harris Melody · CIK 0001880847 · Chf Ops Off, Pres, Informatics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,136

Underlying: Common Stock · 7,068 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: On May 11, 2023, Ms. Harris was granted 21,204 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F4 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-24-000071 · wk-form4_1715737076.xml · nonDerivative · entry 2

Harris Melody · CIK 0001880847 · Chf Ops Off, Pres, Informatics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,301

F2 · shares: Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.

SEC source: 0001077183-24-000071 · wk-form4_1715737076.xml · nonDerivative · entry 1

Harris Melody · CIK 0001880847 · Chf Ops Off, Pres, Informatics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,023

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.

SEC source: 0001077183-24-000169 · wk-form4a_1733346601.xml · derivative · entry 3

Sherman Jeffrey Scott · CIK 0001463145 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,011

Underlying: Common Stock · 13,005 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On May 11, 2023, Mr. Sherman was granted 39,016 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F5 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-24-000169 · wk-form4a_1733346601.xml · nonDerivative · entry 2

Sherman Jeffrey Scott · CIK 0001463145 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,500

F2 · shares: Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.

F3 · balance_after: On May 14, 2024, the reporting person filed a Form 4 which inadvertently reported the number of shares of common stock received upon the vesting of certain of his RSUs twice. In fact, as reported in this amendment, the reporting person directly owned 135,500 shares of common stock after the vesting of 13,005 RSUs and reported withholding.

SEC source: 0001077183-24-000169 · wk-form4a_1733346601.xml · nonDerivative · entry 1

Sherman Jeffrey Scott · CIK 0001463145 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,667

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.

SEC source: 0001077183-24-000170 · wk-form4a_1733346644.xml · derivative · entry 3

Olivo Alicia C · CIK 0001951869 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,006

Underlying: Common Stock · 6,502 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On May 11, 2023, Ms. Olivo was granted 19,508 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F5 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-24-000170 · wk-form4a_1733346644.xml · nonDerivative · entry 2

Olivo Alicia C · CIK 0001951869 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,414

F2 · shares: Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.

F3 · balance_after: On May 14, 2024, the reporting person filed a Form 4 which inadvertently reported the number of shares received upon the vesting of certain of her RSUs twice. In fact, as reported in this amendment, the reporting person directly owned 39,414 shares of common stock after the vesting of 6,502 RSUs and reported withholding. The error effected the number of shares reported in Column 5 of Table I of each of the reporting person's subsequent filings on Form 4.

SEC source: 0001077183-24-000170 · wk-form4a_1733346644.xml · nonDerivative · entry 1

Olivo Alicia C · CIK 0001951869 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,998

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.

SEC source: 0001077183-24-000168 · wk-form4a_1733346539.xml · derivative · entry 3

Smith Christopher M · CIK 0001436707 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,127

Underlying: Common Stock · 48,063 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On May 11, 2023, Mr. Smith was granted 144,190 restricted stock units. These restricted stock units vest ratably over the first three year anniversary dates of the grant date.

F5 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-24-000168 · wk-form4a_1733346539.xml · nonDerivative · entry 2

Smith Christopher M · CIK 0001436707 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 631,369

F2 · shares: Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.

F3 · balance_after: On May 14, 2024, the reporting person filed a Form 4 which inadvertently reported the number of shares of common stock received upon the vesting of certain of his RSUs twice. In fact, as reported in this amendment, the reporting person directly owned 631,369 shares of common stock after the vesting of 48,063 RSUs and reported withholding. The error effected the number of shares reported in Column 5 of Table I of each of the reporting person's subsequent filings on Form 4.

SEC source: 0001077183-24-000168 · wk-form4a_1733346539.xml · nonDerivative · entry 1

Smith Christopher M · CIK 0001436707 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 650,282

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.

SEC source: 0001077183-24-000062 · wk-form4_1714767046.xml · derivative · entry 11

Stone Warren · CIK 0001955295 · Chief Commerical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,908

Underlying: Common Stock · 17,908 shares

Expires not disclosed

F11 · derivative.exercise_date: On May 2, 2024, Mr. Stone was granted 17,908 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 26,862. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.

F4 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-24-000062 · wk-form4_1714767046.xml · derivative · entry 10

Stone Warren · CIK 0001955295 · Chief Commerical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,908

Underlying: Common Stock · 17,908 shares

Expires not disclosed

F10 · derivative.exercise_date: On May 2, 2024, Mr. Stone was granted 17,905 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F4 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-24-000062 · wk-form4_1714767046.xml · derivative · entry 9

Stone Warren · CIK 0001955295 · Chief Commerical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,976

Underlying: Common Stock · 29,976 shares

Expires 2034-05-02

F9 · derivative.exercise_date: On May 2, 2024, Mr. Stone was granted 29,976 stock options. These options vest ratably over the first three anniversary dates of the grant date.

SEC source: 0001077183-24-000060 · wk-form4_1714766939.xml · derivative · entry 11

Harris Melody · CIK 0001880847 · Chf Ops Off, Pres, Informatics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,939

Underlying: Common Stock · 11,939 shares

Expires not disclosed

F11 · derivative.exercise_date: On May 2, 2024, Ms. Harris was granted 11,939 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 17,909. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.

F4 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-24-000060 · wk-form4_1714766939.xml · derivative · entry 10

Harris Melody · CIK 0001880847 · Chf Ops Off, Pres, Informatics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,939

Underlying: Common Stock · 11,939 shares

Expires not disclosed

F10 · derivative.exercise_date: On May 2, 2024, Ms. Harris was granted 11,939 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F4 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-24-000060 · wk-form4_1714766939.xml · derivative · entry 9

Harris Melody · CIK 0001880847 · Chf Ops Off, Pres, Informatics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,984

Underlying: Common Stock · 19,984 shares

Expires 2034-05-02

F9 · derivative.exercise_date: On May 2, 2024, Ms. Harris was granted 19,984 stock options. These options vest ratably over the first three anniversary dates of the grant date.

SEC source: 0001077183-24-000059 · wk-form4_1714766855.xml · derivative · entry 4

Aunan Greg D · CIK 0001646370 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,117

Underlying: Common Stock · 16,117 shares

Expires not disclosed

F4 · derivative.exercise_date: On May 2, 2024, Mr. Aunan was granted 16,117 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F5 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-24-000059 · wk-form4_1714766855.xml · derivative · entry 3

Aunan Greg D · CIK 0001646370 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,978

Underlying: Common Stock · 26,978 shares

Expires 2034-05-02

F3 · derivative.exercise_date: On May 2, 2024, Mr. Aunan was granted 26,978 stock options. These options vest ratably over the first three anniversary dates of the grant date.

SEC source: 0001077183-24-000061 · wk-form4_1714766994.xml · nonDerivative · entry 1

Olivo Alicia C · CIK 0001951869 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,496

F1 · shares: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the May 1, 2024 vesting of restricted stock.

F2 · balance_after: This balance includes 282 shares that were acquired pursuant to NeoGenomics's Employee Stock Purchase Plan (ESPP) since the date of the reporting person's last filing. The shares were acquired in transactions exempt from Section 16b-3.

SEC source: 0001077183-24-000059 · wk-form4_1714766855.xml · nonDerivative · entry 1

Aunan Greg D · CIK 0001646370 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,453

F1 · shares: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the May 1, 2024 vesting of restricted stock.

SEC source: 0001077183-24-000034 · wk-form4_1709760358.xml · nonDerivative · entry 1

TETRAULT LYNN A. · CIK 0001645512 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 50,062

SEC source: 0001077183-24-000031 · wk-form4_1709069363.xml · derivative · entry 8

Stone Warren · CIK 0001955295 · President, Clinical Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,330

Underlying: Common Stock · 25,330 shares

Expires not disclosed

F8 · derivative.exercise_date: On February 23, 2024, Mr. Stone was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 37,996. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.

F4 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-24-000031 · wk-form4_1709069363.xml · derivative · entry 7

Stone Warren · CIK 0001955295 · President, Clinical Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,329

Underlying: Common Stock · 25,329 shares

Expires not disclosed

F7 · derivative.exercise_date: On February 23, 2024, Mr. Stone was granted 25,329 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F4 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-24-000031 · wk-form4_1709069363.xml · derivative · entry 6

Stone Warren · CIK 0001955295 · President, Clinical Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,344

Underlying: Common Stock · 42,344 shares

Expires 2034-02-23

F6 · derivative.exercise_date: On February 23, 2024, Mr. Stone was granted 42,344 stock options. These options vest ratably over the first three anniversary dates of the grant date.

SEC source: 0001077183-24-000030 · wk-form4_1709069329.xml · derivative · entry 13

Olivo Alicia C · CIK 0001951869 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,330

Underlying: Common Stock · 25,330 shares

Expires not disclosed

F13 · derivative.exercise_date: On February 23, 2024, Ms. Olivo was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 37,996. 50% of the number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.

F9 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-24-000030 · wk-form4_1709069329.xml · derivative · entry 12

Olivo Alicia C · CIK 0001951869 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,329

Underlying: Common Stock · 25,329 shares

Expires not disclosed

F12 · derivative.exercise_date: On February 23, 2024, Ms. Olivo was granted 25,329 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F9 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-24-000030 · wk-form4_1709069329.xml · derivative · entry 11

Olivo Alicia C · CIK 0001951869 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,344

Underlying: Common Stock · 42,344 shares

Expires 2034-02-23

F11 · derivative.exercise_date: On February 23, 2024, Ms. Olivo was granted 42,344 stock options. The options vest ratably over the first three anniversary dates of the grant date.

SEC source: 0001077183-24-000029 · wk-form4_1709069299.xml · derivative · entry 8

Sherman Jeffrey Scott · CIK 0001463145 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,606

Underlying: Common Stock · 46,606 shares

Expires not disclosed

F8 · derivative.exercise_date: On February 23, 2024, Mr. Sherman was granted 46,606 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 69,910. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.

F4 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-24-000029 · wk-form4_1709069299.xml · derivative · entry 7

Sherman Jeffrey Scott · CIK 0001463145 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,606

Underlying: Common Stock · 46,606 shares

Expires not disclosed

F7 · derivative.exercise_date: On February 23, 2024, Mr. Sherman was granted 46,606 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F4 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-24-000029 · wk-form4_1709069299.xml · derivative · entry 6

Sherman Jeffrey Scott · CIK 0001463145 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,913

Underlying: Common Stock · 77,913 shares

Expires 2034-02-23

F6 · derivative.exercise_date: On February 23, 2024, Mr. Sherman was granted 77,913 stock options. These options vest ratably over the first three anniversary dates of the grant date.

SEC source: 0001077183-24-000028 · wk-form4_1709069286.xml · derivative · entry 8

Smith Christopher M · CIK 0001436707 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 172,240

Underlying: Common Stock · 172,240 shares

Expires not disclosed

F8 · derivative.exercise_date: On February 23, 2024, Mr. Smith was granted 172,240 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 258,360. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.

F4 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-24-000028 · wk-form4_1709069286.xml · derivative · entry 7

Smith Christopher M · CIK 0001436707 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 172,239

Underlying: Common Stock · 172,239 shares

Expires not disclosed

F7 · derivative.exercise_date: On February 23, 2024, Mr. Smith was granted 172,239 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F4 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-24-000028 · wk-form4_1709069286.xml · derivative · entry 6

Smith Christopher M · CIK 0001436707 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 287,940

Underlying: Common Stock · 287,940 shares

Expires 2034-02-23

F6 · derivative.exercise_date: On February 23, 2024, Mr. Smith was granted 287,940 stock options. These options vest ratably over the first three anniversary dates of the grant date.

SEC source: 0001077183-24-000027 · wk-form4_1709069261.xml · derivative · entry 8

Harris Melody · CIK 0001880847 · President, Enterprise Ops

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,330

Underlying: Common Stock · 25,330 shares

Expires not disclosed

F8 · derivative.exercise_date: On February 23, 2024, Ms. Harris was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 37,996. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.

F4 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-24-000027 · wk-form4_1709069261.xml · derivative · entry 7

Harris Melody · CIK 0001880847 · President, Enterprise Ops

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,329

Underlying: Common Stock · 25,329 shares

Expires not disclosed

F7 · derivative.exercise_date: On February 23, 2024, Ms. Harris was granted 25,329 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F4 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.